Gil J - Search Results

1

The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.

Errarte P, Guarch R, Pulido R, Blanco L, Nunes-Xavier CE, Beitia M, Gil J, Angulo JC, López JI, Larrinaga G. Errarte P, et al. Among authors: gil j. PLoS One. 2016 Dec 29;11(12):e0169105. doi: 10.1371/journal.pone.0169105. eCollection 2016. PLoS One. 2016. PMID: 28033421 Free PMC article.

2

Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma.

Varona A, Blanco L, López JI, Gil J, Agirregoitia E, Irazusta J, Larrinaga G. Varona A, et al. Among authors: gil j. Am J Physiol Renal Physiol. 2007 Feb;292(2):F780-8. doi: 10.1152/ajprenal.00148.2006. Epub 2006 Sep 19. Am J Physiol Renal Physiol. 2007. PMID: 16985214 Free article.

3

Cystinyl aminopeptidase activity is decreased in renal cell carcinomas.

Larrinaga G, López JI, Casis L, Blanco L, Gil J, Agirregoitia E, Varona A. Larrinaga G, et al. Among authors: gil j. Regul Pept. 2007 Dec 4;144(1-3):56-61. doi: 10.1016/j.regpep.2007.06.002. Epub 2007 Jun 21. Regul Pept. 2007. PMID: 17692401

4

Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma.

Larrinaga G, Sanz B, Pérez I, Blanco L, Cándenas ML, Pinto FM, Gil J, López JI. Larrinaga G, et al. Among authors: gil j. J Histochem Cytochem. 2010 Dec;58(12):1129-34. doi: 10.1369/jhc.2010.957126. Epub 2010 Sep 17. J Histochem Cytochem. 2010. PMID: 20852034 Free PMC article.

5

The impact of peptidase activity on clear cell renal cell carcinoma survival.

Larrinaga G, Blanco L, Sanz B, Perez I, Gil J, Unda M, Andrés L, Casis L, López JI. Larrinaga G, et al. Among authors: gil j. Am J Physiol Renal Physiol. 2012 Dec 15;303(12):F1584-91. doi: 10.1152/ajprenal.00477.2012. Epub 2012 Sep 26. Am J Physiol Renal Physiol. 2012. PMID: 23019229 Free article.

6

Altered glutamyl-aminopeptidase activity and expression in renal neoplasms.

Blanco L, Sanz B, Perez I, Sánchez CE, Cándenas ML, Pinto FM, Gil J, Casis L, López JI, Larrinaga G. Blanco L, et al. Among authors: gil j. BMC Cancer. 2014 May 30;14:386. doi: 10.1186/1471-2407-14-386. BMC Cancer. 2014. PMID: 24885240 Free PMC article.

7

Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.

Larrinaga G, Perez I, Sanz B, Beitia M, Errarte P, Fernández A, Blanco L, Etxezarraga MC, Gil J, López JI. Larrinaga G, et al. Among authors: gil j. PLoS One. 2015 Mar 19;10(3):e0119436. doi: 10.1371/journal.pone.0119436. eCollection 2015. PLoS One. 2015. PMID: 25790122 Free PMC article.

8

Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma.

Blanco L, Larrinaga G, Pérez I, López JI, Gil J, Agirregoitia E, Varona A. Blanco L, et al. Among authors: gil j. Am J Physiol Renal Physiol. 2008 Apr;294(4):F850-8. doi: 10.1152/ajprenal.00469.2007. Epub 2008 Jan 23. Am J Physiol Renal Physiol. 2008. PMID: 18216146 Free article.

9

Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent.

Varona A, Blanco L, Perez I, Gil J, Irazusta J, López JI, Candenas ML, Pinto FM, Larrinaga G. Varona A, et al. Among authors: gil j. BMC Cancer. 2010 May 11;10:193. doi: 10.1186/1471-2407-10-193. BMC Cancer. 2010. PMID: 20459800 Free PMC article.

10

Changes in cell-surface peptidase activity in papillary renal cell carcinoma.

Blanco L, Perez I, Sanz B, Gil J, López JI, Ugalde A, Varona A, Larrinaga G. Blanco L, et al. Among authors: gil j. Anticancer Res. 2010 Apr;30(4):1137-41. Anticancer Res. 2010. PMID: 20530419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,095 results

Search Page